Hinge Health (HNGE) Raises Guidance, Expands Buybacks as It Acquires Cylinder Health
Hinge Health (NYSE:HNGE) has raised its full-year revenue guidance for 2026 to between $856 million and $860 million, surpassing analyst expectations. This follows a strong Q2 performance with 53% year-over-year revenue growth to $213 million, along with non-GAAP operating income of $62 million (a 29% margin) and free cash flow reaching $100 million. The company also announced the acquisition of Cylinder Health for $105 million in cash, expanding its digital healthcare offerings beyond musculoskeletal care into gastrointestinal health. Additionally, Hinge Health increased its share repurchase program by $300 million, bringing total authorization to $496.5 million and signaling confidence in long-term value. Analysts from RBC Capital and Truist raised their price targets for the stock while maintaining positive ratings, citing platform expansion and strong growth potential despite near-term billings concerns.
Tickers: $HNGE
Topics: buybacks digital healthcare M&A activity stock performance